mupirocin
- Product NDC
- 17856-0112
- 11-digit product format
- 178560112
- Labeler code
- 17856
- Product ID
- 17856-0112_3633ac1b-d811-2f7b-e063-6394a90a1227
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mupirocin
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- ANDA065123
- Marketing category
- ANDA
- Marketing start
- 2009-10-30
- Substance
- MUPIROCIN
- Active strength
- 20 mg/g
- Pharmacologic classes
- RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- mupirocin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MUPIROCIN | 20 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D0GX863OA5 |
| Rxcui | 106346 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17856-0112-1 | mupirocin | 1 g in 1 SYRINGE | OINTMENT | 1 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17856-0112 | MUPIROCIN OINTMENT [ATLANTIC BIOLOGICALS CORP.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240509_da2f7d4e-82c6-4790-8eea-3a97e5b30734.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 17856-0112-1 | 17856011201 | 1 g in 1 SYRINGE (17856-0112-1) | 1 g | 2024-05-08 | 0000-00-00 | No | No | Current |